Search Results - "Ayers, Mark D"
-
1
The Effects of Cardiac Implantable Electronic Device Personal Protective Equipment Use in Patients with Pediatric and Adult Congenital Heart Disease
Published in Pediatric cardiology (01-12-2023)“…Pediatric and adult congenital heart disease (ACHD) patients encounter physical and emotional barriers. Cardiac implantable electronic devices (CIEDs),…”
Get full text
Journal Article -
2
Novel NKX2.5 variant associated with congenital heart disease and increased risk of malignant arrhythmia and sudden cardiac death
Published in Cardiology in the young (01-03-2024)“…The NKX2.5 gene is an important cardiac developmental transcription factor, and variants in this gene are most commonly associated with CHD. However, there is…”
Get more information
Journal Article -
3
Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry
Published in European heart journal (14-09-2023)“…Abstract Aims Calmodulinopathy due to mutations in any of the three CALM genes (CALM1–3) causes life-threatening arrhythmia syndromes, especially in young…”
Get full text
Journal Article -
4
Life-threatening cardiac arrhythmia and sudden death during electronic gaming: An international case series and systematic review
Published in Heart rhythm (01-11-2022)“…BACKGROUNDElectronic gaming has recently been reported as a precipitant of life-threatening cardiac arrhythmia in susceptible individuals. OBJECTIVEThe purpose…”
Get full text
Journal Article -
5
Complete Atrioventricular Heart Block From an Epilepsy Treatment
Published in Pediatric neurology (01-03-2018)Get full text
Journal Article -
6
All Along the Watchtower: a Case of Long QT Syndrome Misdiagnosis Secondary to Genetic Testing Misinterpretation
Published in Journal of genetic counseling (01-12-2018)“…Clinical genetics services continue to expand into diverse medical specialties. An ever-increasing number of non-genetics providers are independently ordering…”
Get full text
Journal Article -
7
Clinical characterisation of a novel SCN5A variant associated with progressive malignant arrhythmia and dilated cardiomyopathy
Published in Cardiology in the young (01-10-2019)“…The SCN5A gene is implicated in many arrhythmogenic and cardiomyopathic processes. We identified a novel SCN5A variant in a family with significant segregation…”
Get more information
Journal Article -
8
The Genetic Counselor in the Pediatric Arrhythmia Clinic: Review and Assessment of Services
Published in Journal of genetic counseling (01-06-2018)“…There are minimal data on the impact of genetic counselors in subspecialty clinics, including the pediatric arrhythmia clinic. This study aimed to describe the…”
Get full text
Journal Article -
9
Near-infrared Spectroscopy to Assess Cerebral Perfusion during Head-up Tilt-table Test in Patients with Syncope
Published in Congenital heart disease (01-07-2015)“…Neurocardiogenic syncope (NCS) is the most common cause of syncope in children and adolescents. Neurocardiogenic syncope occurs secondary to cerebral…”
Get more information
Journal Article -
10
The successful use of verapamil in infants with fascicular ventricular tachycardia
Published in Progress in pediatric cardiology (01-12-2022)“…A case report of a 7 day old neonate and a 16 month old infant both of whom presented with sustained tachyarrhythmia that was identified as fascicular…”
Get full text
Journal Article -
11
-
12
-
13
The effects of progestin-only hormone treatment on QT interval in the adolescent female
Published in Progress in pediatric cardiology (01-12-2021)“…Prolongation of the ECG derived QT interval predicts increased risk for sudden life-threatening arrhythmias. Many medicines are known to prolong the QT…”
Get full text
Journal Article -
14
Abstract 256: Identification of additional cancers likely to respond to anti-PD-1 therapy (pembrolizumab): Evaluation of PD-L1 expression in a large molecular tumor profiling gene expression database
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Abstract Increased PD-L1 expression has been associated with clinical activity of anti-PD-1/PD-L1 therapies in both melanoma and non-small cell lung cancer…”
Get full text
Journal Article -
15
Abstract 1307: Assessment of gene expression in peripheral blood from patients with advanced melanoma using RNA-seq before and after treatment with anti-PD-1 therapy with pembrolizumab (MK-3475)
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Abstract Pembrolizumab (MK-3475) is a humanized monoclonal IgG4 antibody against programmed death receptor 1 (PD-1) that is currently being studied in clinical…”
Get full text
Journal Article